CRAC

Crown Reserve Acquisition Corp.

Bullish Trend

Near 52W High

$10.18+$0.00 (+0.00%)

Loading Chart...

Institutional Signal // Day Trade Edge:Neutral / No Active Setup Today

Scan Active Universe on Day Trade Edge

Key Statistics

Market Cap227.71M

Forward P/E—

EPS (TTM)—

52-Week Return+2.83%

50-Day Moving Avg$10.15

200-Day Moving Avg$10.05

Volume Today11

Avg Volume28.33K

Day Range$10.18 – $10.18

52-Week Range$9.89 – $10.21

Open Price$10.18

Previous Close$10.18

Company Profile

Description

Crown Reserve Acquisition Corp. I does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Grand Cayman, Cayman Islands.

Sector

Financial Services

Industry

Shell Companies

CEO

Mr. Prashant Patel M.Sc., R.Ph.

SEC Filings

EDGAR Filings

Exchange Listing

Nasdaq.com

Company Profile

Description

Sector

Financial Services

Industry

Shell Companies

CEO

Mr. Prashant Patel M.Sc., R.Ph.

SEC Filings

EDGAR Filings

Exchange Listing

Nasdaq.com

CRAC

Key Statistics

Company Profile

Company Profile

Recent News

CalciMedica Announces One-for-Five Reverse Stock Split

CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints

Global Data Center Market Investment to Reach USD 959.19 Billion by 2031- Exclusive Insight by Arizton

Greece Data Center Market Trends & Investment Analysis, 2026-2031 | Amazon Boosts Greece's Renewable Energy Initiative with New Wind Farm PPAs

Belgium Data Center Market Report 2026-2031 | The Rise in AI and IoT Applications Fuels the Demand for Robust Data Center Infrastructure

CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program

CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data

Recent News

Company Profile

Recent News

CalciMedica Announces One-for-Five Reverse Stock Split

CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints

Global Data Center Market Investment to Reach USD 959.19 Billion by 2031- Exclusive Insight by Arizton

Greece Data Center Market Trends & Investment Analysis, 2026-2031 | Amazon Boosts Greece's Renewable Energy Initiative with New Wind Farm PPAs

Belgium Data Center Market Report 2026-2031 | The Rise in AI and IoT Applications Fuels the Demand for Robust Data Center Infrastructure

CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program

CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data